{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:26:36Z","timestamp":1770711996518,"version":"3.49.0"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["F.18-1\/2011(BSR)"],"award-info":[{"award-number":["F.18-1\/2011(BSR)"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Deregulated DNA damage response (DDR) network is implicated in\ncancer progression and therapy resistance.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The present study was designed to investigate whether nimbolide, an anticancer neem\nlimonoid, targets key components of the DDR signalling pathway in cellular and animal models\nof oral squamous cell carcinoma (OSCC).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>OSCC cells (SCC-4 and SCC-9), 7,12-dimethylbenz[a]anthracene (DMBA)-induced\nhamster buccal pouch (HBP) carcinoma model, chemoresistant OSCC patient-derived xenograft\n(PDX) model established in athymic nude mice, and tissue sections from patients with oral\npremalignant\/malignant disease were used for the study. Key molecules that orchestrate the\nDDR, including the MRN complex, ATM, DNA-PKcs, H2AX, and p53, were analysed by qRTPCR,\nimmunoblotting, immunofluorescence, and immunohistochemistry. Cell proliferation and\napoptosis indices were evaluated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Nimbolide significantly reduced 8-oxodG levels, expression of MRN, ATMS1891, and \u03b3H2AX, with an increase in p-p53S15 in OSCC cells as well as in the HBP model. Nimbolide potentiated the effect of KU-55933 in ATM inhibition. In the PDX model, nimbolide suppressed\ntumor formation, stimulated DDR and apoptosis, inhibited cell proliferation, and enhanced sensitivity to cisplatin. Analysis of p-ATM expression revealed a significant increase during the sequential progression of hamster and human OSCC.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>This study provides compelling evidence that nimbolide functions as a DDR inhibitor\nin cellular and hamster OSCC models and as a DDR activator in the PDX model primarily by\ntargeting ATM. Small molecules like nimbolide that modulate DDR are of immense benefit in\ncancer therapy. The study has also unveiled p-ATM as a promising biomarker of tumour progression\nin human OSCCs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010291998240321074920","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T03:27:14Z","timestamp":1712028434000},"page":"428-442","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma"],"prefix":"10.2174","volume":"26","author":[{"given":"Soundararajan","family":"Arvindh","sequence":"first","affiliation":[{"name":"Department of Biochemistry &amp; Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, 608002,\nTamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manashi","family":"Priyadarshini","sequence":"additional","affiliation":[{"name":"Institute of Life Sciences, Bhubaneswar, Odisha, 751023, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Basit","family":"Baba","sequence":"additional","affiliation":[{"name":"Advanced Centre for Human\nGenetics, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, Jammu &amp; Kashmir, 190011, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veeran","family":"Veeravarmal","sequence":"additional","affiliation":[{"name":"Division\nof Oral and Maxillofacial Pathology, Government Dental College and Hospital, Cuddalore District, 608 002, Tamil\nNadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1735-2411","authenticated-orcid":true,"given":"Rajakishore","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand,\nRatu-Lohardaga Road, Brambe, Ranchi, 835205, Jharkhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupesh","family":"Dash","sequence":"additional","affiliation":[{"name":"Institute of Life Sciences, Bhubaneswar, Odisha, 751023, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8889-6013","authenticated-orcid":true,"given":"Siddavaram","family":"Nagini","sequence":"additional","affiliation":[{"name":"Department of Biochemistry &amp; Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, 608002,\nTamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.sintl.2020.100046","volume":"1","author":"Borse V.","year":"2020","unstructured":"Borse V.; Konwar A.N.; Buragohain P.; Oral cancer diagnosis and perspectives in India. Sensors International  2020,1,100046","journal-title":"Sensors International"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3332\/ecancer.2021.1252","volume":"15","author":"Singh A.G.","year":"2021","unstructured":"Singh A.G.; Chaukar D.; Gupta S.; Pramesh C.S.; Sullivan R.; Chaturvedi P.; Badwe R.; A prospective study to determine the cost of illness for oral cancer in India. Ecancermedicalscience  2021,15,1252","journal-title":"Ecancermedicalscience"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/ijpvm.IJPVM_403_18","volume":"11","author":"Irani S.","year":"2020","unstructured":"Irani S.; New insights into oral cancer\u2014Risk factors and prevention: A review of literature. Int J Prev Med  2020,11(1),202","journal-title":"Int J Prev Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3390\/ijms24032673","volume":"24","author":"Pomella S.","year":"2023","unstructured":"Pomella S.; Cassandri M.; Melaiu O.; Marampon F.; Gargari M.; Campanella V.; Rota R.; Barillari G.; DNA damage response gene signature as potential treatment markers for oral squamous cell carcinoma. Int J Mol Sci  2023,24(3),2673","journal-title":"Int J Mol Sci"},{"key":"ref=6","first-page":"314","volume":"18","author":"Taghavi N.","year":"2015","unstructured":"Taghavi N.; Yazdi I.; Prognostic factors of survival rate in oral squamous cell carcinoma: Clinical, histologic, genetic and molecular concepts. Arch Iran Med  2015,18(5),314-319","journal-title":"Arch Iran Med"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-9411-3_63","author":"Nagini S.","year":"2022","unstructured":"Nagini S.; Thiyagarajan P.; Rao K.S.; Interplay between reactive oxygen species and key players in the DNA damage response signaling network. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects  2022","journal-title":"Handbook of Oxidative Stress in Cancer: Mechanistic Aspects"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"Blackford A.N.","year":"2017","unstructured":"Blackford A.N.; Jackson S.P.; ATM, ATR, and DNA-PK: The trinity at the heart of the DNA damage response. Mol Cell  2017,66(6),801-817","journal-title":"Mol Cell"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.3390\/molecules26237198","volume":"26","author":"Merighi A.","year":"2021","unstructured":"Merighi A.; Gionchiglia N.; Granato A.; Lossi L.; The phosphorylated form of the histone H2AX (\u03b3H2AX) in the brain from embryonic life to old age. Molecules  2021,26(23),7198","journal-title":"Molecules"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","volume":"54","author":"Abuetabh Y.","year":"2022","unstructured":"Abuetabh Y.; Wu H.H.; Chai C.; Al Yousef H.; Persad S.; Sergi C.M.; Leng R.; DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. Exp Mol Med  2022,54(10),1658-1669","journal-title":"Exp Mol Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"14672","DOI":"10.3390\/ijms232314672","volume":"23","author":"Jurkovicova D.","year":"2022","unstructured":"Jurkovicova D.; Neophytou C.M.; Ga\u0161parovi\u0107 A.\u010c.; Gon\u00e7alves A.C.; DNA damage response in cancer therapy and resistance: Challenges and opportunities. Int J Mol Sci  2022,23(23),14672","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/cancers15020448","volume":"15","author":"Ovejero-S\u00e1nchez M.","year":"2023","unstructured":"Ovejero-S\u00e1nchez M.; Gonz\u00e1lez-Sarmiento R.; Herrero A.B.; DNA damage response alterations in ovarian cancer: From molecular mechanisms to therapeutic opportunities. Cancers  2023,15(2),448","journal-title":"Cancers"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.3390\/ijms24032760","volume":"24","author":"Papalouka C.","year":"2023","unstructured":"Papalouka C.; Adamaki M.; Batsaki P.; Zoumpourlis P.; Tsintarakis A.; Goulielmaki M.; Fortis S.P.; Baxevanis C.N.; Zoumpourlis V.; DNA damage response mechanisms in head and neck cancer: Significant implications for therapy and survival. Int J Mol Sci  2023,24(3),2760","journal-title":"Int J Mol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3390\/ijms23031701","volume":"23","author":"Choi W.","year":"2022","unstructured":"Choi W.; Lee E.S.; Therapeutic targeting of DNA damage response in cancer. Int J Mol Sci  2022,23(3),1701","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4161\/cbt.23761","volume":"14","author":"Woods D.","year":"2013","unstructured":"Woods D.; Turchi J.J.; Chemotherapy induced DNA damage response. Cancer Biol Ther  2013,14(5),379-389","journal-title":"Cancer Biol Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.dnarep.2018.04.004","volume":"66-67","author":"Desai A.","year":"2018","unstructured":"Desai A.; Yan Y.; Gerson S.L.; Advances in therapeutic targeting of the DNA damage response in cancer. DNA Repair  2018,66-67,24-29","journal-title":"DNA Repair"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-med-081313-121208","volume":"66","author":"Goldstein M.","year":"2015","unstructured":"Goldstein M.; Kastan M.B.; The DNA damage response: Implications for tumor responses to radiation and chemotherapy. Annu Rev Med  2015,66(1),129-143","journal-title":"Annu Rev Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"Pili\u00e9 P.G.","year":"2019","unstructured":"Pili\u00e9 P.G.; Tang C.; Mills G.B.; Yap T.A.; State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol  2019,16(2),81-104","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"103074","DOI":"10.1016\/j.dnarep.2021.103074","volume":"101","author":"Sadoughi F.","year":"2021","unstructured":"Sadoughi F.; Mirsafaei L.; Dana P.M.; Hallajzadeh J.; Asemi Z.; Mansournia M.A.; Montazer M.; Hosseinpour M.; Yousefi B.; The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem? DNA Repair  2021,101,103074","journal-title":"DNA Repair"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"115279","DOI":"10.1016\/j.bmc.2019.115279","volume":"28","author":"van Stuijvenberg J.","year":"2020","unstructured":"van Stuijvenberg J.; Proksch P.; Fritz G.; Targeting the DNA damage response (DDR) by natural compounds. Bioorg Med Chem  2020,28(4),115279","journal-title":"Bioorg Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.semcancer.2020.02.013","volume":"68","author":"Brinkman J.A.","year":"2021","unstructured":"Brinkman J.A.; Liu Y.; Kron S.J.; Small-molecule drug repurposing to target DNA damage repair and response pathways. Semin Cancer Biol  2021,68,230-241","journal-title":"Semin Cancer Biol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.3390\/ijms22189766","volume":"22","author":"Chen C.C.","year":"2021","unstructured":"Chen C.C.; Chen C.Y.; Cheng S.F.; Shieh T.M.; Leu Y.L.; Chuang W.Y.; Liu K.T.; Ueng S.H.; Shih Y.H.; Chou L.F.; Wang T.H.; Hydroxygenkwanin increases the sensitivity of liver cancer cells to chemotherapy by inhibiting DNA damage response in mouse xenograft models. Int J Mol Sci  2021,22(18),9766","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","volume":"23","author":"Groelly F.J.","year":"2023","unstructured":"Groelly F.J.; Fawkes M.; Dagg R.A.; Blackford A.N.; Tarsounas M.; Targeting DNA damage response pathways in cancer. Nat Rev Cancer  2023,23(2),78-94","journal-title":"Nat Rev Cancer"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2020.08.008","volume":"493","author":"Tian D.","year":"2020","unstructured":"Tian D.; Tang J.; Geng X.; Li Q.; Wang F.; Zhao H.; Narla G.; Yao X.; Zhang Y.; Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy. Cancer Lett  2020,493,80-90","journal-title":"Cancer Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.apsb.2021.08.025","volume":"12","author":"Wang F.","year":"2022","unstructured":"Wang F.; Jin S.; Mayca Pozo F.; Tian D.; Tang X.; Dai Y.; Yao X.; Tang J.; Zhang Y.; Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR. Acta Pharm Sin B  2022,12(3),1339-1350","journal-title":"Acta Pharm Sin B"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1021\/acs.jmedchem.0c02239","volume":"64","author":"Nagini S.","year":"2021","unstructured":"Nagini S.; Nivetha R.; Palrasu M.; Mishra R.; Nimbolide, a neem limonoid, is a promising candidate for the anticancer drug arsenal. J Med Chem  2021,64(7),3560-3577","journal-title":"J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/med.21988","volume":"44","author":"Nagini S.","year":"2024","unstructured":"Nagini S.; Palrasu M.; Bishayee A.; Limonoids from neem ( Azadirachta indica A. Juss.) are potential anticancer drug candidates. Med Res Rev  2024,44(2),457-496","journal-title":"Med Res Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"44790","DOI":"10.18632\/oncotarget.8316","volume":"7","author":"Wang L.","year":"2016","unstructured":"Wang L.; Phan D.D.K.; Zhang J.; Ong P.S.; Thuya W.L.; Soo R.; Wong A.L.A.; Yong W.P.; Lee S.C.; Ho P.C.L.; Sethi G.; Goh B.C.; Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development. Oncotarget  2016,7(28),44790-44802","journal-title":"Oncotarget"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/tox.22576","volume":"33","author":"Hsueh K.C.","year":"2018","unstructured":"Hsueh K.C.; Lin C.L.; Tung J.N.; Yang S.F.; Hsieh Y.H.; Nimbolide induced apoptosis by activating ERK\u2010mediated inhibition of c\u2010IAP1 expression in human hepatocellular carcinoma cells. Environ Toxicol  2018,33(9),913-922","journal-title":"Environ Toxicol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/s41598-017-01960-5","volume":"7","author":"Kowshik J.","year":"2017","unstructured":"Kowshik J.; Mishra R.; Sophia J.; Rautray S.; Anbarasu K.; Reddy G.D.; Dixit M.; Mahalingam S.; Nagini S.; Nimbolide upregulates RECK by targeting miR-21 and HIF-1\u03b1 in cell lines and in a hamster oral carcinogenesis model. Sci Rep  2017,7(1),2045","journal-title":"Sci Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"153826","DOI":"10.1016\/j.phymed.2021.153826","volume":"94","author":"Mahmoud N.","year":"2022","unstructured":"Mahmoud N.; Dawood M.; Huang Q.; Ng J.P.L.; Ren F.; Wong V.K.W.; Efferth T.; Nimbolide inhibits 2D and 3D prostate cancer cells migration, affects microtubules and angiogenesis and suppresses B-RAF\/p.ERK-mediated in vivo tumor growth. Phytomedicine  2022,94,153826","journal-title":"Phytomedicine"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/bab.2258","volume":"69","author":"Nath N.","year":"2022","unstructured":"Nath N.; Rana A.; Nagini S.; Mishra R.; Glycogen synthase kinase\u20103\u03b2 inactivation promotes cervical cancer progression, invasion, and drug resistance. Biotechnol Appl Biochem  2022,69(5),1929-1941","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3753587","volume":"2019","author":"Shin S.S.","year":"2019","unstructured":"Shin S.S.; Hwang B.; Muhammad K.; Gho Y.; Song J.H.; Kim W.J.; Kim G.; Moon S.K.; Nimbolide represses the proliferation, migration, and invasion of bladder carcinoma cells via chk2-mediated G2\/M phase cell cycle arrest, altered signaling pathways, and reduced transcription factors-associated MMP-9 expression. Evid Based Complement Alternat Med  2019,2019,1-12","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"105293","DOI":"10.1016\/j.tiv.2021.105293","volume":"79","author":"Singh D.","year":"2022","unstructured":"Singh D.; Mohapatra P.; Kumar S.; Behera S.; Dixit A.; Sahoo S.K.; Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells. Toxicol In vitro  2022,79,105293","journal-title":"Toxicol In vitro"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41419-018-1126-4","volume":"9","author":"Sophia J.","year":"2018","unstructured":"Sophia J.; Kowshik J.; Dwivedi A.; Bhutia S.K.; Manavathi B.; Mishra R.; Nagini S.; Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K\/Akt\/GSK-3\u03b2 signalling pathway in oral cancer. Cell Death Dis  2018,9(11),1087","journal-title":"Cell Death Dis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"22192","DOI":"10.1038\/srep22192","volume":"6","author":"Sophia J.","year":"2016","unstructured":"Sophia J.; Kiran Kishore T K.; Kowshik J.; Mishra R.; Nagini S.; Nimbolide, a neem limonoid inhibits phosphatidyl inositol-3 kinase to activate glycogen synthase kinase-3\u03b2 in a hamster model of oral oncogenesis. Sci Rep  2016,6(1),22192","journal-title":"Sci Rep"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2012.01.024","volume":"681","author":"Kavitha K.","year":"2012","unstructured":"Kavitha K.; Vidya Priyadarsini R.; Anitha P.; Ramalingam K.; Sakthivel R.; Purushothaman G.; Singh A.K.; Karunagaran D.; Nagini S.; Nimbolide, a neem limonoid abrogates canonical NF-\u03baB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells. Eur J Pharmacol  2012,681(1-3),6-14","journal-title":"Eur J Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3109\/10715761003692503","volume":"44","author":"Priyadarsini R.V.","year":"2010","unstructured":"Priyadarsini R.V.; Murugan R.S.; Sripriya P.; Karunagaran D.; Nagini S.; The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells. Free Radic Res  2010,44(6),624-634","journal-title":"Free Radic Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"eadg7752","DOI":"10.1126\/sciadv.adg7752","volume":"9","author":"Li P.","year":"2023","unstructured":"Li P.; Zhen Y.; Kim C.; Liu Z.; Hao J.; Deng H.; Deng H.; Zhou M.; Wang X.D.; Qin T.; Yu Y.; Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA -mutated cancer. Sci Adv  2023,9(43),eadg7752","journal-title":"Sci Adv"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e0141719","DOI":"10.1371\/journal.pone.0141719","volume":"10","author":"Bundela S.","year":"2015","unstructured":"Bundela S.; Sharma A.; Bisen P.S.; Potential compounds for oral cancer treatment: resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine. PLoS One  2015,10(11),e0141719","journal-title":"PLoS One"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods  1983,65(1-2),55-63","journal-title":"J Immunol Methods"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2174\/1871520622666220204115151","volume":"22","author":"Nivetha R.","year":"2022","unstructured":"Nivetha R.; Arvindh S.; Baba A.B.; Gade D.R.; Gopal G.; K C.; Reddy K.P.; Reddy G.B.; Nagini S.; Nimbolide, a neem limonoid, inhibits angiogenesis in breast cancer by abrogating aldose reductase mediated IGF-1\/PI3K\/Akt signalling. Anticancer Agents Med Chem  2022,22(14),2619-2636","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"Lowry O.","year":"1951","unstructured":"Lowry O.; Rosebrough N.; Farr A.L.; Randall R.; Protein measurement with the folin phenol reagent. J Biol Chem  1951,193(1),265-275","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"103027","DOI":"10.1016\/j.dnarep.2020.103027","volume":"97","author":"Gorini F.","year":"2021","unstructured":"Gorini F.; Scala G.; Cooke M.S.; Majello B.; Amente S.; Towards a comprehensive view of 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine: Highlighting the intertwined roles of DNA damage and epigenetics in genomic instability. DNA Repair  2021,97,103027","journal-title":"DNA Repair"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0092-8674(00)00073-8","volume":"102","author":"Oda K.","year":"2000","unstructured":"Oda K.; Arakawa H.; Tanaka T.; Matsuda K.; Tanikawa C.; Mori T.; Nishimori H.; Tamai K.; Tokino T.; Nakamura Y.; Taya Y.; p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell  2000,102(6),849-862","journal-title":"Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3390\/cancers14040953","volume":"14","author":"Martorana F.","year":"2022","unstructured":"Martorana F.; Da Silva L.A.; Sessa C.; Colombo I.; Everything comes with a price: The toxicity profile of DNA-damage response targeting agents. Cancers  2022,14(4),953","journal-title":"Cancers"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00784-015-1506-4","volume":"20","author":"Kaur J.","year":"2016","unstructured":"Kaur J.; Politis C.; Jacobs R.; Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action. Clin Oral Investig  2016,20(2),315-319","journal-title":"Clin Oral Investig"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"e105994","DOI":"10.1371\/journal.pone.0105994","volume":"9","author":"Zhang M.","year":"2014","unstructured":"Zhang M.; Hou M.; Ge L.; Miao C.; Zhang J.; Jing X.; Shi N.; Chen T.; Tang X.; Induction of peroxiredoxin 1 by hypoxia regulates heme oxygenase-1 via NF-\u03baB in oral cancer. PLoS One  2014,9(8),e105994","journal-title":"PLoS One"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.31557\/APJCP.2020.21.8.2325","volume":"21","author":"Nandakumar A.","year":"2020","unstructured":"Nandakumar A.; Nataraj P.; James A.; Krishnan R.; K M M.; Estimation of salivary 8-hydroxydeoxyguanosine (8-OHdG) as a potential biomarker in assessing progression towards malignancy: A case-control study. Asian Pac J Cancer Prev  2020,21(8),2325-2329","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.oraloncology.2009.01.006","volume":"45","author":"Nagini S.","year":"2009","unstructured":"Nagini S.; Letchoumy P.V.; A T.; Cr R.; Of humans and hamsters: A comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol  2009,45(6),e31-e37","journal-title":"Oral Oncol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/cells11040641","volume":"11","author":"Chen Y.C.","year":"2022","unstructured":"Chen Y.C.; Yang C.W.; Chan T.F.; Farooqi A.A.; Chang H.S.; Yen C.H.; Huang M.Y.; Chang H.W.; Cryptocaryone promotes ROS-dependent antiproliferation and apoptosis in ovarian cancer cells. Cells  2022,11(4),641","journal-title":"Cells"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/tox.22516","volume":"33","author":"Tang J.Y.","year":"2018","unstructured":"Tang J.Y.; Huang H.W.; Wang H.R.; Chan Y.C.; Haung J.W.; Shu C.W.; Wu Y.C.; Chang H.W.; 4\u03b2\u2010Hydroxywithanolide E selectively induces oxidative DNA damage for selective killing of oral cancer cells. Environ Toxicol  2018,33(3),295-304","journal-title":"Environ Toxicol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.2147\/OTT.S190460","volume":"12","author":"Tang J.Y.","year":"2019","unstructured":"Tang J.Y.; Yu T.J.; Lin L.C.; Peng S.Y.; Wang C.L.; Ou-Yang F.; Cheng Y.B.; Chang H.W.; Ethyl acetate extracts of Nepenthes ventricosa x sibuyanensis leaves cause growth inhibition against oral cancer cells via oxidative stress. OncoTargets Ther  2019,12,5227-5239","journal-title":"OncoTargets Ther"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/cbin.11862","volume":"46","author":"Wang Q.","year":"2022","unstructured":"Wang Q.; Zhang L.; Xiao Y.; Ghaemnezhad A.; Diosgenin promotes cisplatin\u2010induced apoptosis through oxidative DNA damage in A549 non\u2010small cell lung cells. Cell Biol Int  2022,46(10),1571-1576","journal-title":"Cell Biol Int"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3389\/fonc.2020.01536","volume":"10","author":"Yen C.J.","year":"2020","unstructured":"Yen C.J.; Hung C.H.; Tsai W.M.; Cheng H.C.; Yang H.L.; Lu Y.J.; Tsai K.L.; Effect of exercise training on exercise tolerance and level of oxidative stress for head and neck cancer patients following chemotherapy. Front Oncol  2020,10,1536","journal-title":"Front Oncol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/biom11091313","volume":"11","author":"Darling-Reed S.F.","year":"2021","unstructured":"Darling-Reed S.F.; Nkrumah-Elie Y.; Ferguson D.T.; Flores-Rozas H.; Mendonca P.; Messeha S.; Hudson A.; Badisa R.B.; Tilghman S.L.; Womble T.; Day A.; Jett M.; Hammamieh R.; Soliman K.F.A.; Diallyl sulfide attenuation of carcinogenesis in mammary epithelial cells through the inhibition of ROS formation, and DNA strand breaks. Biomolecules  2021,11(9),1313","journal-title":"Biomolecules"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.21873\/anticanres.13095","volume":"39","author":"De Moura C.F.G.","year":"2019","unstructured":"De Moura C.F.G.; Soares G.R.; Ribeiro F.A.P.; Silva M.J.D.; Vilegas W.; Santamarina A.B.; Pisani L.P.; Estadella D.; Ribeiro D.A.; Evaluation of the chemopreventive activity of grape skin extract using medium-term oral carcinogenesis assay induced by 4-nitroquinoline 1-oxide. Anticancer Res  2019,39(1),177-182","journal-title":"Anticancer Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1038\/s41388-021-01698-5","volume":"40","author":"Wang Y.Y.","year":"2021","unstructured":"Wang Y.Y.; Chen Y.K.; Lo S.; Chi T.C.; Chen Y.H.; Hu S.C.S.; Chen Y.W.; Jiang S.S.; Tsai F.Y.; Liu W.; Li R.N.; Hsieh Y.C.; Huang C.J.; Yuan S.S.F.; MRE11 promotes oral cancer progression through RUNX2\/CXCR4\/AKT\/FOXA2 signaling in a nuclease-independent manner. Oncogene  2021,40(20),3510-3532","journal-title":"Oncogene"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.05.013","volume":"514","author":"Wang Y.Y.","year":"2021","unstructured":"Wang Y.Y.; Hung A.C.; Lo S.; Hsieh Y.C.; Yuan S.S.F.; MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy. Cancer Lett  2021,514,1-11","journal-title":"Cancer Lett"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00432-008-0365-7","volume":"134","author":"He Y.","year":"2008","unstructured":"He Y.; Chen Q.; Li B.; ATM in oral carcinogenesis: Association with clinicopathological features. J Cancer Res Clin Oncol  2008,134(9),1013-1020","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"27117","DOI":"10.1074\/jbc.M602826200","volume":"281","author":"Colton S.L.","year":"2006","unstructured":"Colton S.L.; Xu X.S.; Wang Y.A.; Wang G.; The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment. J Biol Chem  2006,281(37),27117-27125","journal-title":"J Biol Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12032-023-02005-w","volume":"40","author":"Khadela A.","year":"2023","unstructured":"Khadela A.; Postwala H.; Rana D.; Dave H.; Ranch K.; Boddu S.H.S.; A review of recent advances in the novel therapeutic targets and immunotherapy for lung cancer. Med Oncol  2023,40(5),152","journal-title":"Med Oncol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","volume":"8","author":"Golding S.E.","year":"2009","unstructured":"Golding S.E.; Rosenberg E.; Valerie N.; Hussaini I.; Frigerio M.; Cockcroft X.F.; Chong W.Y.; Hummersone M.; Rigoreau L.; Menear K.A.; O\u2019Connor M.J.; Povirk L.F.; van Meter T.; Valerie K.; Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther  2009,8(10),2894-2902","journal-title":"Mol Cancer Ther"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"Hickson I.","year":"2004","unstructured":"Hickson I.; Zhao Y.; Richardson C.J.; Green S.J.; Martin N.M.B.; Orr A.I.; Reaper P.M.; Jackson S.P.; Curtin N.J.; Smith G.C.M.; Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res  2004,64(24),9152-9159","journal-title":"Cancer Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"492","DOI":"10.18632\/aging.204487","volume":"15","author":"Chiu L.Y.","year":"2022","unstructured":"Chiu L.Y.; Sun Q.; Zenke F.T.; Blaukat A.; Vassilev L.T.; Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death. Aging  2022,15(2),492-512","journal-title":"Aging"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","volume":"4","author":"Durant S. T.","year":"2018","unstructured":"Durant S. T.; Zheng L.; Wang Y.; Chen K.; Zhang L.; Zhang T.; Yang Z.; Riches L.; Trinidad A. G.; Fok J. H. L.; Hunt T.; Pike K. G.; Wilson J.; Smith A.; Colclough N.; Reddy V. P.; Sykes A.; Janefeldt A.; Johnstr\u00f6m P.; Pass M.; The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv  2018,4(6),eaat1719","journal-title":"Sci Adv"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1021\/acs.jmedchem.7b01896","volume":"61","author":"Pike K.G.","year":"2018","unstructured":"Pike K.G.; Barlaam B.; Cadogan E.; Campbell A.; Chen Y.; Colclough N.; Davies N.L.; de-Almeida C.; Degorce S.L.; Didelot M.; Dishington A.; Ducray R.; Durant S.T.; Hassall L.A.; Holmes J.; Hughes G.D.; MacFaul P.A.; Mulholland K.R.; McGuire T.M.; Al-Huniti N.; The identification of potent, selective, and orally available inhibitors of ataxia telangiectasia mutated (ATM) kinase: The discovery of AZD0156 (8-{6-[3-(dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H -pyran-4-yl)-1,3-dihydro-2 H -imidazo[4,5- c ]quinolin-2-one). J Med Chem  2018,61(9),3823-3841","journal-title":"J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8239984","volume":"2021","author":"Pan S.T.","year":"2021","unstructured":"Pan S.T.; Huang G.; Wang Q.; Qiu J.X.; Plumbagin enhances the radiosensitivity of tongue squamous cell carcinoma cells via downregulating ATM. J Oncol  2021,2021,1-11","journal-title":"J Oncol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2016.08.002","volume":"61","author":"Low G.M.","year":"2016","unstructured":"Low G.M.; Thylur D.S.; Yamamoto V.; Sinha U.K.; The effect of human papillomavirus on DNA repair in head and neck squamous cell carcinoma. Oral Oncol  2016,61,27-30","journal-title":"Oral Oncol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.oooo.2018.03.006","volume":"125","author":"Nikitakis N.G.","year":"2018","unstructured":"Nikitakis N.G.; Rassidakis G.Z.; Tasoulas J.; Gkouveris I.; Kamperos G.; Daskalopoulos A.; Sklavounou A.; Alterations in the expression of DNA damage response-related molecules in potentially preneoplastic oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol  2018,125(6),637-649","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"383","DOI":"10.18632\/oncoscience.47","volume":"1","author":"Oliveira-Costa J.P.","year":"2014","unstructured":"Oliveira-Costa J.P.; Oliveira L.R.; Zanetti J.S.; Silveira G.G.; Buim M.E.C.; Zucoloto S.; Ribeiro-Silva A.; Soares F.A.; Soares F.A.; BRCA1 and \u03b3H2AX as independent prognostic markers in oral squamous cell carcinoma. Oncoscience  2014,1(5),383-391","journal-title":"Oncoscience"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.taap.2013.08.013","volume":"272","author":"Ganesan S.","year":"2013","unstructured":"Ganesan S.; Bhattacharya P.; Keating A.F.; 7,12-Dimethylbenz[a]anthracene exposure induces the DNA repair response in neonatal rat ovaries. Toxicol Appl Pharmacol  2013,272(3),690-696","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/0022034518759068","volume":"97","author":"Lindemann A.","year":"2018","unstructured":"Lindemann A.; Takahashi H.; Patel A.A.; Osman A.A.; Myers J.N.; Targeting the DNA damage response in OSCC with TP53 mutations. J Dent Res  2018,97(6),635-644","journal-title":"J Dent Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jmcb\/mjz060","volume":"11","author":"Liu Y.","year":"2019","unstructured":"Liu Y.; Tavana O.; Gu W.; p53 modifications: Exquisite decorations of the powerful guardian. J Mol Cell Biol  2019,11(7),564-577","journal-title":"J Mol Cell Biol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1111\/cas.13792","volume":"109","author":"Yogosawa S.","year":"2018","unstructured":"Yogosawa S.; Yoshida K.; Tumor suppressive role for kinases phosphorylating p53 in  damage\u2010induced apoptosis. Cancer Sci  2018,109(11),3376-3382","journal-title":"Cancer Sci"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010291998240321074920","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228442\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010291998240321074920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T10:51:20Z","timestamp":1738234280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228442\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010291998240321074920","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}